Medical data market sees billion-dollar deals for de-identified patient records
A company acquired de-identified medical records of approximately 50 million Americans for about $1 billion in 2021. The data, sourced from hospitals, includes diagnoses, prescriptions, and lab results stripped of personal identifiers. This information is highly valued for AI training due to its longitudinal, labeled, and multimodal nature. The market for such clinical data involves insurers, pharmaceutical companies, and AI labs. Critics argue that de-identification does not guarantee anonymity and that patient consent for treatment does not cover data use for commercial AI development.
This is an AI-generated summary. ShortSingh links to the original source for the complete article.
Discussion (0)
Log in to join the discussion and vote.
Log in